These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18948576)

  • 1. A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene.
    Yin B; Delwel R; Valk PJ; Wallace MR; Loh ML; Shannon KM; Largaespada DA
    Blood; 2009 Jan; 113(5):1075-85. PubMed ID: 18948576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.
    Chang T; Krisman K; Theobald EH; Xu J; Akutagawa J; Lauchle JO; Kogan S; Braun BS; Shannon K
    J Clin Invest; 2013 Jan; 123(1):335-9. PubMed ID: 23221337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.
    Wiesner SM; Geurts JL; Diers MD; Bergerson RJ; Hasz DE; Morgan KJ; Largaespada DA
    Am J Hematol; 2011 Jul; 86(7):579-85. PubMed ID: 21681782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency.
    Sachs Z; Been RA; DeCoursin KJ; Nguyen HT; Mohd Hassan NA; Noble-Orcutt KE; Eckfeldt CE; Pomeroy EJ; Diaz-Flores E; Geurts JL; Diers MD; Hasz DE; Morgan KJ; MacMillan ML; Shannon KM; Largaespada DA; Wiesner SM
    Haematologica; 2016 Oct; 101(10):1190-1199. PubMed ID: 27418650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral integration site analysis identifies ICSBP as a collaborating tumor suppressor gene in NUP98-TOP1-induced leukemia.
    Gurevich RM; Rosten PM; Schwieger M; Stocking C; Humphries RK
    Exp Hematol; 2006 Sep; 34(9):1192-201. PubMed ID: 16939812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia.
    Largaespada DA; Brannan CI; Jenkins NA; Copeland NG
    Nat Genet; 1996 Feb; 12(2):137-43. PubMed ID: 8563750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of p21(WAF1/CIP1) as an attenuator of both proliferative and drug-induced apoptotic signals in BCR-ABL-transformed hematopoietic cells.
    Forster K; Obermeier A; Mitina O; Simon N; Warmuth M; Krause G; Hallek M
    Ann Hematol; 2008 Mar; 87(3):183-93. PubMed ID: 17960378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL11A expression in acute phase chronic myeloid leukemia.
    Yin J; Zhang F; Tao H; Ma X; Su G; Xie X; Xu Z; Zheng Y; Liu H; He C; Mao ZJ; Wang Z; Chang W; Gale RP; Wu D; Yin B
    Leuk Res; 2016 Aug; 47():88-92. PubMed ID: 27285855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl11a is essential for lymphoid development and negatively regulates p53.
    Yu Y; Wang J; Khaled W; Burke S; Li P; Chen X; Yang W; Jenkins NA; Copeland NG; Zhang S; Liu P
    J Exp Med; 2012 Dec; 209(13):2467-83. PubMed ID: 23230003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic SETBP1 mutations in myeloid neoplasms.
    Makishima H
    Int J Hematol; 2017 Jun; 105(6):732-742. PubMed ID: 28447248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice.
    Cutts BA; Sjogren AK; Andersson KM; Wahlstrom AM; Karlsson C; Swolin B; Bergo MO
    Blood; 2009 Oct; 114(17):3629-32. PubMed ID: 19710506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Lu D; Nounou R; Beran M; Estey E; Manshouri T; Kantarjian H; Keating MJ; Albitar M
    Cancer; 2003 Jan; 97(2):441-9. PubMed ID: 12518368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras.
    Kalra R; Paderanga DC; Olson K; Shannon KM
    Blood; 1994 Nov; 84(10):3435-9. PubMed ID: 7949098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1.
    Steinemann D; Arning L; Praulich I; Stuhrmann M; Hasle H; Stary J; Schlegelberger B; Niemeyer CM; Flotho C
    Haematologica; 2010 Feb; 95(2):320-3. PubMed ID: 20015894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of the adhesion molecules P-selectin and intercellular adhesion molecule-1 accelerate the development of BCR/ABL-induced chronic myeloid leukemia-like myeloproliferative disease in mice.
    Pelletier SD; Hong DS; Hu Y; Liu Y; Li S
    Blood; 2004 Oct; 104(7):2163-71. PubMed ID: 15213099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein.
    Yang G; Khalaf W; van de Locht L; Jansen JH; Gao M; Thompson MA; van der Reijden BA; Gutmann DH; Delwel R; Clapp DW; Hiebert SW
    Mol Cell Biol; 2005 Jul; 25(14):5869-79. PubMed ID: 15988004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline Neurofibromin 1 mutation enhances the anti-tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicity.
    Wang W; Li X; Qin X; Miao Y; Zhang Y; Li S; Yao R; Yang Y; Yu L; Zhu H; Song L; Mao S; Wang X; Chen J; Feng H; Li Y
    Br J Haematol; 2023 Jul; 202(2):328-343. PubMed ID: 37144690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
    Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism.
    Melo-Cardenas J; Xu Y; Wei J; Tan C; Kong S; Gao B; Montauti E; Kirsammer G; Licht JD; Yu J; Ji P; Crispino JD; Fang D
    Blood; 2018 Jul; 132(4):423-434. PubMed ID: 29844011
    [No Abstract]   [Full Text] [Related]  

  • 20. Tie2-Cre-induced inactivation of a conditional mutant Nf1 allele in mouse results in a myeloproliferative disorder that models juvenile myelomonocytic leukemia.
    Gitler AD; Kong Y; Choi JK; Zhu Y; Pear WS; Epstein JA
    Pediatr Res; 2004 Apr; 55(4):581-4. PubMed ID: 14739366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.